Scientific Advisory Board

The Scientific Advisory Board (SAB) was created in 2002 to provide ongoing, high-level scientific advice to IPM. IPM’s scientific agenda is based on a set of decision-making criteria approved by the SAB in 2003. Due to its size, the full SAB does not meet regularly. IPM staff consults as needed with individual SAB members who have expertise in particular areas of microbicide research and/or drug development. IPM provides SAB members with updates on its work, including a comprehensive annual report on its science program.

IPM established an SAB Executive Committee to meet annually, beginning in 2006. The Executive Committee is comprised of members from the broader SAB with particular expertise in drug development, antiretroviral science, microbicide development, clinical evaluation, delivery system expertise and other relevant areas. The Executive Committee reviews IPM’s scientific agenda and work over the previous year, and advises IPM staff on their research plans and priorities for the coming year.

	Summary of SAB Executive Committee Meeting - December 2007
	Summary of SAB Executive Committee Meeting - November 2006
	Executive Committee Members
	Board Members

Executive Committee Members

Dr. Robin Shattock, Chair Bio Professor in Molecular Infection, Centre for Infection, Department of Cellular and Molecular Medicine, St. George's, University of London, United Kingdom     Dr. Richard Bax Vice President, Clinical Development and Medical Affairs, ViroPharma Europe, United Kingdom     Mr. Ben Cheng Deputy Director, Forum for Collaborative HIV Research, The George Washington University, USA     Dr. Gustavo F. Doncel Director of CONRAD Preclinical Research and Professor of Obstetrics and Gynecology, Eastern Virginia Medical School, USA     Dr. Sharon L. Hillier Professor, Department of Obstetrics, Gynecology and Reproductive Sciences and the Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine Director, Infectious Disease Research and Director, Center of Excellence in Women's Health, Magee-Womens Hospital,USA

Dr. Ruth Merkatz Project Director, Contraceptive Development, Population Council Center for Biomedical Research, USA     Dr. Thomas Moench Medical Director, ReProtect, Inc., USA     Dr. Lynn Paxton Chief, Sexual Transmission and Injection Drug Use Studies Section, AIDS EPE Branch, DHAP-SE, Centers for Disease Control and Prevention, USA     Dr. Gita Ramjee Professor and Director, HIV/AIDS Lead Programme & HIV Prevention Research Unit, South Africa     Dr. Martin Springer Merck & Co., Inc., Retired, USA     Dr. Jens van Roey Director of Global Clinical Development, Tibotec BVBA, Belgium

Board Members

Dr. Salim Abdool Karim Director, Centre for the AIDS Programme of Research, University of KwaZulu-Natal, South Africa     Dr. Chris Beyrer Associate Professor of Epidemiology and International Health, Johns Hopkins Bloomberg School of Health Director, JHU Fogarty AIDS International Training and Research Program Director, The Center for Public Health and Human Rights, JHU, USA     Dr. Tsungai Chipato Senior Lecturer in Obstetrics and Gynaecology, College of Health Sciences, University of Zimbabwe Principal Investigator, University of Zimbabwe-UCSF HIV Prevention Trials Unit, Zimbabwe     Dr. Robert Coombs Professor, Laboratory Medicine & Medicine, University of Washington, USA     Dr. Thomas Folks Chief, HIV and Retrovirology Branch Division of AIDS, STD, and Laboratory Research, National Center for Infectious Diseases, Centers for Disease Control and Prevention, USA     Dr. Sanjay Garg Associate Professor and Deputy Head, School of Pharmacy, University of Auckland, New Zealand     Dr. Scott Hammer Professor of Medicine and Public Health (Epidemiology), Columbia University, USA     Dr. Betsy C. Herold Professor of Pediatrics & Microbiology, Mount Sinai School of Medicine Chief, Division of Pediatric Infectious Disease, USA     Mr. Chris Irwin Associate Director, Skin Care Product Development, Procter & Gamble, USA     Dr. Newton Kumwenda Epidemiologist, College of Medicine, Malawi     Dr. Joep Lange Professor of Medicine, Center for Poverty-related Communicable Diseases, Academic Medical Center, University of Amsterdam, The Netherlands

Dr. Roger Le Grand Head of Neurovirology Department, Commissariat à l'Energie Atomique, DSV/DRM, France     Dr. Karl Malcolm Lecturer in Pharmaceutics, School of Pharmacy, Queen's University of Belfast, Northern Ireland, United Kingdom     Dr. Kenneth Mayer Professor of Medicine and Community Health, Brown University/Miriam Hospital, USA     Dr. Ian McGowan Associate Professor of Medicine, University of California at Los Angeles, David Geffen School of Medicine, USA     Dr. Sanjay Mehendale Deputy Director, Division of Epidemiology, National AIDS Research Institute, India     Dr. John Mellors Chief, Division of Infectious Diseases and Director of the HIV/AIDS Program, University of Pittsburgh Medical Center, USA     Mr. Jay Nash Principal Scientist, Procter & Gamble, USA     Prof. Helen Rees Executive Director, Reproductive Health and HIV Research Unit, Witwatersrand University, South Africa     Mr. Paul Tanner Research Fellow, Procter & Gamble, USA     Dr. Ron Veazey Professor of Pathology, Tulane University School of Medicine Chair, Division of Comparative Pathology, Tulane National Primate Research Center, USA     Dr. Mark Wainberg Director, McGill University AIDS Centre, Canada     Dr. David Woolfson Professor of Pharmaceutics, Queen’s University of Belfast, Northern Ireland